| PMID | Title | Display |
|---|
| 12709400 | Activation of the hypoxia-inducible factor-pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors. |    |
|
| 12770927 | Thymidine phosphorylase induces angiogenesis in vivo and in vitro: an evaluation of possible mechanisms. | |
|
| 14528035 | Inhibited angiogenesis in aging: a role for TIMP-2. | |
|
| 14563940 | COX-2/VEGF-dependent facilitation of tumor-associated angiogenesis and tumor growth in vivo. | |
|
| 14612527 | Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy. | |
|
| 14732224 | Psammaplin A, a marine natural product, inhibits aminopeptidase N and suppresses angiogenesis in vitro. | |
|
| 15054866 | Study of puupehenone and related compounds as inhibitors of angiogenesis. | |
|
| 15106730 | Generation of a specific immunological response to FGF-2 does not affect wound healing or reproduction. | |
|
| 15215251 | Vascular endothelial growth factor (VEGF)-D and VEGF-A differentially regulate KDR-mediated signaling and biological function in vascular endothelial cells. | |
|
| 15653332 | Polybrominated diphenyl ethers from a sponge of the Dysidea genus that inhibit Tie2 kinase. | |
|
